Collapsibility Index of the Inferior Vena Cava and Kidney Transplantation

Launched by CHU DE REIMS · Jan 23, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a tool called the inferior vena cava variability index, which helps doctors understand how well a patient's body is responding to fluid after kidney transplantation. Fluid management is important because many patients experience issues with their new kidney function after surgery. The researchers believe that using this index can help improve care for patients in the days following their transplant, potentially speeding up the recovery of kidney function.

To participate in this study, patients need to have end-stage renal disease and must be hospitalized at the Reims University Hospital for a kidney transplant. They should also be willing to give their consent to join the study and be receiving extra fluids after their surgery. Participants can expect to undergo some non-invasive tests that will help monitor their response to fluid, which could lead to better management of their care during this critical time. It’s important to note that patients who cannot provide clear ultrasound images or have certain measurement issues may not be eligible for the trial.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Diagnosis of End-stage renal disease (ESRD)
• • Hospitalization in the nephrology intensive care unit at Reims University Hospital
• • Hospitalization due to renal transplantation
• • Willingness to provide informed consent and participate in the study
• • Receiving volume expansion following renal transplantation.
• Exclusion criteria:
• • Inability to obtain high-quality ultrasound images
• • Unavailability of Intra-vesical pressure and central venous pressure measurements